UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1399) 1399
science & technology (1316) 1316
life sciences & biomedicine (1270) 1270
female (1047) 1047
oncology (1000) 1000
topotecan - administration & dosage (980) 980
topotecan (941) 941
middle aged (649) 649
chemotherapy (641) 641
biological and medical sciences (625) 625
medical sciences (623) 623
male (605) 605
adult (588) 588
aged (586) 586
antineoplastic combined chemotherapy protocols - therapeutic use (575) 575
antineoplastic agents (508) 508
pharmacology. drug treatments (494) 494
topotecan - adverse effects (399) 399
ovarian neoplasms - drug therapy (337) 337
topotecan - therapeutic use (331) 331
treatment outcome (326) 326
cancer (321) 321
antineoplastic agents - administration & dosage (319) 319
drug administration schedule (317) 317
antineoplastic agents - therapeutic use (302) 302
animals (289) 289
tumors (260) 260
pharmacology & pharmacy (248) 248
antineoplastic combined chemotherapy protocols - adverse effects (243) 243
lung neoplasms - drug therapy (228) 228
topotecan - pharmacokinetics (228) 228
neoplasm recurrence, local - drug therapy (221) 221
ovarian cancer (221) 221
camptothecin - analogs & derivatives (216) 216
dose-response relationship, drug (213) 213
antineoplastic agents - adverse effects (204) 204
paclitaxel - administration & dosage (202) 202
cisplatin - administration & dosage (195) 195
mice (189) 189
antineoplastic combined chemotherapy protocols - administration & dosage (187) 187
infusions, intravenous (177) 177
aged, 80 and over (176) 176
carboplatin - administration & dosage (173) 173
antineoplastic agents - pharmacokinetics (164) 164
topotecan - pharmacology (162) 162
neoplasms - drug therapy (160) 160
adolescent (154) 154
child (154) 154
child, preschool (153) 153
care and treatment (151) 151
drug resistance, neoplasm (144) 144
etoposide - administration & dosage (140) 140
obstetrics & gynecology (140) 140
topoisomerase i inhibitors (139) 139
disease-free survival (138) 138
survival rate (136) 136
cell line, tumor (130) 130
neoplasm staging (129) 129
research (129) 129
ovarian neoplasms - pathology (128) 128
medicine & public health (127) 127
survival analysis (126) 126
antineoplastic agents - pharmacology (123) 123
hematology (122) 122
camptothecin - administration & dosage (120) 120
retrospective studies (118) 118
carcinoma, small cell - drug therapy (113) 113
combined modality therapy (113) 113
administration, oral (112) 112
deoxycytidine - analogs & derivatives (109) 109
doxorubicin - administration & dosage (109) 109
prognosis (106) 106
infant (104) 104
clinical trials (101) 101
antimitotic agents (100) 100
drug therapy (99) 99
deoxycytidine - administration & dosage (98) 98
hematology, oncology and palliative medicine (98) 98
lung neoplasms - pathology (98) 98
analysis (91) 91
cyclophosphamide - administration & dosage (89) 89
pediatrics (89) 89
pharmacokinetics (89) 89
toxicity (89) 89
camptothecin - therapeutic use (88) 88
maximum tolerated dose (88) 88
follow-up studies (87) 87
neutropenia - chemically induced (87) 87
paclitaxel (87) 87
cisplatin (83) 83
topoisomerase i inhibitors - administration & dosage (82) 82
irinotecan (81) 81
lung cancer (79) 79
pharmacology/toxicology (79) 79
recurrence (78) 78
carboplatin (77) 77
etoposide (77) 77
cancer therapies (75) 75
gynecology. andrology. obstetrics (75) 75
drug synergism (73) 73
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1618) 1618
French (12) 12
Japanese (12) 12
Chinese (11) 11
German (4) 4
Hungarian (4) 4
Italian (4) 4
Polish (3) 3
Portuguese (3) 3
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Japanese journal of clinical oncology, ISSN 0368-2811, 05/2015, Volume 45, Issue 5, pp. 408 - 410
Chemo-gynecology | Molecular Dx | Gynecol-med | Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Humans | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Folic Acid - administration & dosage | TOR Serine-Threonine Kinases - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - administration & dosage | Vinca Alkaloids - administration & dosage | Benzimidazoles - administration & dosage | Doxorubicin - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Antimetabolites, Antineoplastic - pharmacology | Female | Quinazolines - administration & dosage | Antineoplastic Agents - pharmacology | Paclitaxel - administration & dosage | Everolimus | Ovarian Neoplasms - drug therapy | Recombinant Fusion Proteins - administration & dosage | Doxorubicin - administration & dosage | Sirolimus - analogs & derivatives | Folic Acid - analogs & derivatives | Phthalazines - administration & dosage | Pyrimidines - administration & dosage | Deoxycytidine - administration & dosage | Angiogenesis Inhibitors - pharmacology | Carboplatin - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors | Polyethylene Glycols - administration & dosage | Sirolimus - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Nivolumab | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Topotecan - administration & dosage | Deoxycytidine - analogs & derivatives | Sulfonamides - administration & dosage | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2017, Volume 35, Issue 29, pp. 3347 - 3353
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 13, pp. 1302 - 1308
Journal Article
European journal of haematology, ISSN 0902-4441, 03/2010, Volume 84, Issue 3, pp. 266 - 270
dexamethasone | refractory disease | cyclophosphamide | thalidomide | transplantation | Hodgkin's lymphoma | Cyclophosphamide | Transplantation | Dexamethasone | Refractory disease | Thalidomide | Life Sciences & Biomedicine | Hematology | Science & Technology | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Humans | Salvage Therapy | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Vinblastine - administration & dosage | Hodgkin Disease - surgery | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Organoplatinum Compounds - administration & dosage | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Dexamethasone - administration & dosage | Deoxycytidine - administration & dosage | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Vidarabine - analogs & derivatives | Bleomycin - administration & dosage | Thalidomide - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Melphalan - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Topotecan - administration & dosage | Mechlorethamine - administration & dosage | Vidarabine - administration & dosage | Peripheral Blood Stem Cell Transplantation | Deoxycytidine - analogs & derivatives | Carmustine - administration & dosage | Antimitotic agents | Stem cells | Antineoplastic agents | Hodgkin's disease | Steroids | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 11/2017, Volume 23, Issue 21, pp. 6441 - 6449
Life Sciences & Biomedicine | Oncology | Science & Technology | Drug-Related Side Effects and Adverse Reactions - blood | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Neuroblastoma - blood | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Neoplasm Recurrence, Local - drug therapy | Infant | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Neoplasm Recurrence, Local - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Dacarbazine - analogs & derivatives | Killer Cells, Natural - immunology | Camptothecin - administration & dosage | Female | Child | Neoplasm Recurrence, Local - blood | Neuroblastoma - pathology | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Dacarbazine - administration & dosage | Gangliosides - antagonists & inhibitors | Interleukin-2 Receptor alpha Subunit - blood | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cell- and Tissue-Based Therapy | Gangliosides - immunology | Disease-Free Survival | Ifosfamide - administration & dosage | Neuroblastoma - drug therapy | Adolescent | Topotecan - administration & dosage | Drug-Related Side Effects and Adverse Reactions - classification | Interleukin-2 - blood | Toxicity | Cytotoxicity | Malignancy | Neuroblastoma | Cerebrospinal fluid | Pain | Interleukin 2 | Surgery | Myelosuppression | Children | Natural killer cells | Antibody-dependent cell-mediated cytotoxicity | Thrombocytopenia | Immune response | Cytokines | Ifosfamide | Granulocyte-macrophage colony-stimulating factor | Hypersensitivity | Etoposide | Pharmacology | Patients | Irinotecan | Cyclophosphamide | Chemotherapy | Experimental design | Monoclonal antibodies | Carboplatin | Temozolomide | Pharmacokinetics | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1247 - 1258
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 13, pp. 1309 - 1316
Journal Article
Clinical cancer research, ISSN 1078-0432, 04/2014, Volume 20, Issue 8, pp. 2104 - 2114
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 500 - 514
Journal Article